NCT02361034View on ClinicalTrials.gov

To Evaluate Safety, Tolerability and Pharmacokinetics of GRC 27864 in Healthy Subjects and Elderly Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

GRC 27864

DRUG

Placebo

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd, Leeds

Sponsors
All Listed Sponsors
lead

Glenmark Pharmaceuticals S.A.

INDUSTRY

NCT02361034 - To Evaluate Safety, Tolerability and Pharmacokinetics of GRC 27864 in Healthy Subjects and Elderly Healthy Subjects | Biotech Hunter | Biotech Hunter